FIBROCHIRFibrocytes' Role in Bronchial Remodelling of COPD
This study aims to screen and observe the increase in the number of fibrocytes, both in the blood and around the bronchial area, at various stages of Chronic Obstructive Pulmonary Disease (COPD), comparing the results to healthy control subjects.
analyse the distribution and quantify the number of the peri-bronchial and blood circulating fibrocytes in patients
+ analyse the distribution and quantify the number of the peri-bronchial and blood circulating fibrocytes in patients
+ analyse the distribution and quantify the number of the peri-bronchial and blood circulating fibrocytes in patients
Chronic Disease+6
+ Lung Diseases
+ Lung Diseases, Obstructive
Screening Study
Summary
Study start date: April 10, 2013
Actual date on which the first participant was enrolled.Chronic Obstructive Pulmonary Disease (COPD) is a lung condition where the airways become damaged and thickened, making it hard to breathe. This damage is often caused by ongoing inflammation. The role of specific cells called fibrocytes in this process is not well understood, even though they are known to contribute to similar issues in other lung diseases. This study aims to explore the involvement of fibrocytes in COPD, focusing on individuals at different stages of the disease compared to healthy subjects. Understanding this could provide valuable insights into the progression of COPD and potentially lead to improved treatment strategies. The study involves analyzing the number and distribution of fibrocytes in the blood and around the airways of COPD patients. By comparing these findings with those from healthy individuals, researchers hope to identify any patterns or trends. The primary outcome of the study is to determine if there is an increase in the number of fibrocytes as the severity of COPD progresses. This information could shed light on the role these cells play in the development and worsening of COPD.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.50 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Screening Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 40 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.3 intervention groups are designated in this study
33.333% chance of being blinded to the placebo group
Treatment Groups
Group I
ExperimentalGroup II
PlaceboGroup III
Active ComparatorStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
University hospital of Bordeaux, Hôpital du Haut Lévêque
Pessac, FranceOpen University hospital of Bordeaux, Hôpital du Haut Lévêque in Google Maps